CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 5, 2014
February 15, 2024
67341cfe-8a48-4fc7-9817-6f9ed89768cf
Related Documents
Expedited Programs for Serious Conditions | Drugs and Biologics
Guidance DocumentMay 30, 2014Center for Drug Evaluation and Research
Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application
Guidance DocumentJuly 17, 2009Center for Drug Evaluation and Research
Dear Health Care Provider Letters: Improving Communication of Important Safety Information
Guidance DocumentJanuary 2, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.